New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 31, 2014
06:41 EDTGRFS, HOLXGrifols announces 7-year agreement with Japanese Red Cross
Grifols (GRFS) announced that it was selected by the Japanese Red Cross Society to be its partner in nucleic acid screening of the country's 5.3M annual blood donations. Under the terms of the 7-year agreement, Grifols will provide the JRC with its newest automation platform, the Procleix Panther System and associated assays, which the JRC will use to screen blood donations for HIV and Hepatitis viruses prior to their release for medical use. The Grifols Procleix brand products are developed as part of a partnership with Hologic (HOLX).
News For GRFS;HOLX From The Last 14 Days
Check below for free stories on GRFS;HOLX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 25, 2014
08:34 EDTGRFSGrifols recent pullback a buying opportunity, says Morgan Stanley at Morgan Stanley
Morgan Stanley views the recent pullback in Grifols as a buying opportunity. The firm said Q2 results were disappointing but there is no change to fundamentals and expects 2H improvement. Shares are Overweight rated with a $44 price target, down from $48.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use